Enertopia (ENRT) 10-K 21 Nov 18 2018 FY Annual report Financial data

Document and Entity Information

Document and Entity Information - USD ($)	12 Months Ended
	Aug. 31, 2018	Nov. 19, 2018	Feb. 28, 2018
Document Type	10-K
Amendment Flag	false
Document Period End Date	Aug. 31, 2018
Trading Symbol	enrt
Entity Registrant Name	Enertopia Corp.
Entity Central Index Key	1,346,022
Current Fiscal Year End Date	--08-31
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		121,964,931
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Well Known Seasoned Issuer	No
Entity Public Float			$ 5,559,000
Document Fiscal Year Focus	2,018
Document Fiscal Period Focus	FY

BALANCE SHEETS

BALANCE SHEETS - USD ($)	Aug. 31, 2018	Aug. 31, 2017
Current
Cash and cash equivalents	$ 176,409	$ 150,870
Accounts receivable	7,504	9,060
Prepaid expenses and deposit	87,777	18,782
Total current assets	271,690	178,712
Non-Current
Long term investments	0	1
Lithium technology	0	12,500
Total Assets	271,690	191,213
Current
Accounts payable	278,036	287,706
Due to related parties	171,234	141,035
Total Current Liabilities	449,270	428,741
STOCKHOLDERS' EQUITY
Share capital Authorized: 200,000,000 common shares with a par value of $0.001 per share Issued and outstanding: 119,739,931 common shares at August 31, 2018 and August 31,2017: 102,298,031	119,741	102,299
Additional paid-in capital	13,594,497	12,901,936
Deficit accumulated during the exploration stage	(13,891,818)	(13,241,763)
Total Stockholders' Equity	(177,580)	(237,528)
Total Liabilities and Stockholders' Equity	$ 271,690	$ 191,213

BALANCE SHEETS (Parenthetical)

BALANCE SHEETS (Parenthetical) - $ / shares	Aug. 31, 2018	Aug. 31, 2017
Common Stock, Shares Authorized	200,000,000	200,000,000
Common Stock, Par Value Per Share	$ 0.001	$ 0.001
Common Stock, Shares, Issued	119,739,931	102,298,031
Common Stock, Shares, Outstanding	119,739,931	102,298,031

STATEMENTS OF STOCKHOLDERS' EQU

STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)	COMMON STOCK [Member]	ADDITIONAL PAID-IN CAPITAL [Member]	DEFICIT ACCUMULATED [Member]	Total
Beginning Balance at Aug. 31, 2016	$ 89,528	$ 12,214,934	$ (12,440,597)	$ (136,135)
Beginning Balance (Shares) at Aug. 31, 2016	89,528,460
Stock Based Compensation		227,428		227,428
Shares issued for private placement on September 23	$ 3,859	93,792		97,651
Shares issued for private placement on September 23 (Shares)	3,858,571
Shares issued for Definitive Agreement on October 7	$ 175	6,825		7,000
Shares issued for Definitive Agreement on October 7 (Shares)	175,000
Shares issued for Private Placement on January 20	$ 1,000	28,600		29,600
Shares issued for Private Placement on January 20 (Shares)	1,000,000
Shares issued for Private Placement on February 28	$ 4,250	115,119		119,369
Shares issued for Private Placement on February 28 (Shares)	4,250,000
Warrant conversion on April 21	$ 96	5,590		5,686
Warrant conversion on April 21 (Shares)	95,500
Warrant conversion on April 28	$ 167	11,488		11,655
Warrant conversion on April 28 (Shares)	166,500
Shares issued for Private Placement on Apr 28	$ 3,224	198,160		201,384
Shares issued for Private Placement on Apr 28 (Shares)	3,224,000
Comprehensive income (loss):			(801,166)	(801,166)
Ending Balance at Aug. 31, 2017	$ 102,299	12,901,936	(13,241,763)	(237,528)
Ending Balance (Shares) at Aug. 31, 2017	102,298,031
Stock Based Compensation		89,596		89,596
Shares issued for Private Placement on November 1	$ 2,600	98,598		101,198
Shares issued for Private Placement on November 1 (Shares)	2,600,000
Shares issued for Private Placement on December 8	$ 3,954	140,505		144,459
Shares issued for Private Placement on December 8 (Shares)	3,954,000
Option conversion on December 8	$ 240	11,760		12,000
Option conversion on December 8 (Shares)	240,000
Shares issued for Private Placement on January 12	$ 1,611	59,657		61,268
Shares issued for Private Placement on January 12 (Shares)	1,611,000
Warrant conversion on February 2	$ 50	3,450		3,500
Warrant conversion on February 2 (Shares)	50,000
Option conversion on May 11	$ 200	11,800		12,000
Option conversion on May 11 (Shares)	200,000
Shares issued for Private Placement on May 11	$ 1,747	72,982		74,729
Shares issued for Private Placement on May 11 (Shares)	1,746,900
Shares issued for Private Placement on May 25	$ 2,470	107,864		110,334
Shares issued for Private Placement on May 25 (Shares)	2,470,000
Shares issued for Private Placement on August 31	$ 4,400	87,519		91,919
Shares issued for Private Placement on August 31 (Shares)	4,400,000
Option conversion on August 31	$ 170	8,830		9,000
Option conversion on August 31 (Shares)	170,000
Comprehensive income (loss):			(650,055)	(650,055)
Ending Balance at Aug. 31, 2018	$ 119,741	$ 13,594,497	$ (13,891,818)	$ (177,580)
Ending Balance (Shares) at Aug. 31, 2018	119,739,931

STATEMENTS OF OPERATIONS

STATEMENTS OF OPERATIONS - USD ($)	12 Months Ended
	Aug. 31, 2018	Aug. 31, 2017
Expenses
Accounting and audit	$ 52,490	$ 64,455
Bank charges and interest expense	1,282	2,210
Consulting	44,604	136,585
Mineral exploration costs	11,465	61,609
Fees and dues	31,659	30,432
Insurance	13,477	12,770
Investor relations	129,437	119,302
Legal and professional	11,318	11,100
Office and miscellaneous	4,186	4,338
Research and development	230,550	20,810
Rent	5,379	15,824
Stock based compensation	89,596	227,428
Telephone	1,791	2,972
Training & Conferences	0	1,643
Travel	10,594	15,397
Total expenses	637,828	726,875
(Loss) for the period before other items	(637,828)	(726,875)
Other income (expense)
Foreign exchange gain (loss)	274	9,144
Write down of long term investments in affiliated company	(1)	(1)
Gain (loss) on marketable securities	0	12,316
Write down of lithium technology	(12,500)	0
Write down of properties	0	(95,750)
Net loss and comprehensive loss for the period	$ (650,055)	$ (801,166)
Basic and diluted loss per share	$ (0.01)	$ (0.01)
Weighted average number of common shares outstanding - basic and diluted	109,821,751	97,249,025

STATEMENTS OF CASH FLOWS

STATEMENTS OF CASH FLOWS - USD ($)	12 Months Ended
	Aug. 31, 2018	Aug. 31, 2017
Cash flows used in operating activities
Net Loss	$ (650,055)	$ (801,166)
Changes to reconcile net loss to net cash used in operating activities
Stock based compensation	89,596	227,428
Write down of lithium technology	12,500	0
Write down of properties	0	95,750
(Gain) loss from sale of securities	0	(12,316)
Write down of long term investments	1	1
Change in non-cash working capital items:
Accounts receivable	1,556	1,952
Prepaid expenses and deposit	(68,995)	64,504
Accounts payable and accrued liabilities	(9,670)	51,464
Due to related parties	30,199	2,112
Net cash (used in) operating activities	(594,868)	(370,271)
Cash flows from (used in) investing activities
Proceeds from sale of marketable securities	0	31,096
Mineral resource properties acquisition	0	(5,000)
Net cash from investing activities	0	26,096
Cash flows from financing activities
Proceeds from Options exercised	33,000	0
Proceeds from Warrants exercised	3,500	17,341
Net proceeds from subscriptions received	583,907	446,670
Net cash from financing activities	620,407	464,011
Increase (Decrease) in cash and cash equivalents	25,539	119,836
Cash and cash equivalents, beginning of period	150,870	31,034
Cash and cash equivalents, end of period	176,409	150,870
Supplemental information of cash flows
Interest paid in cash	0	0
Income taxes paid in cash	0	0
Shares issued for mineral property	$ 0	$ 7,000

ORGANIZATION

ORGANIZATION	12 Months Ended
	Aug. 31, 2018
ORGANIZATION [Text Block]	1. ORGANIZATION The Company was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. The Company was an independent natural resource company engaged in the exploration, development and acquisition of natural resources in the United States and Canada. In the fiscal year 2010, the Company shifted its strategic plan from its non-renewal energy operations to its planned renewal energy operations and natural resource acquisition and development. In late summer of 2013, the Company had another business sector in alternative health and wellness. During spring of 2016, the Company shifted its strategic plan to natural resource acquisitions and Lithium brine extraction technology. The Company has offices in Vancouver and Kelowna, B.C., Canada.

GOING CONCERN UNCERTAINTY

GOING CONCERN UNCERTAINTY	12 Months Ended
	Aug. 31, 2018
GOING CONCERN UNCERTAINTY [Text Block]	2. GOING CONCERN UNCERTAINTY The accompanying financial statements have been prepared on a going concern basis which contemplates the realization of assets and the satisfaction of liabilities and commitments in the normal course of business for the foreseeable future. The Company had a working capital deficit of $177,580 for the year ended August 31, 2018 (deficit of $250,029 for the year ended August 31, 2017). The Company incurred a net loss of $650,055 for the year ended August 31, 2018 (net loss of $801,166 for the year ended August 31, 2017) and as at August 31, 2018 has incurred cumulative losses of $13,891,818 that raises substantial doubt about its ability to continue as a going concern. Management has been able, thus far, to finance the operations through equity financing and cash on hand. There is no assurance that the Company will be able to continue to finance the Company on this basis. In view of these conditions, the ability of the Company to continue as a going concern is in substantial doubt and dependent upon its ability to generate sufficient cash flow to meet its obligations on a timely basis, to obtain additional financing as may be required, to receive the continued support of the Company’s shareholders, and ultimately to obtain successful operations. There are no assurances that we will be able to obtain further funds required for our continued operations. As noted herein, we are pursuing various financing alternatives to meet our immediate and long-term financial requirements. There can be no assurance that additional financing will be available to us when needed or, if available, that it can be obtained on commercially reasonable terms. If we are not able to obtain the additional financing on a timely basis, we will be unable to conduct our operations as planned, and we will not be able to meet our other obligations as they become due. In such event, we will be forced to scale down or perhaps even cease our operations. There is significant uncertainty as to whether we can obtain additional financing. These financial statements do not give effect to any adjustments which would be necessary should the Company be unable to continue as a going concern and therefore be required to realize its assets and discharge its liabilities in other than the normal course of business and at amounts different from those reflected in the accompanying financial statements.

SIGNIFICANT ACCOUNTING POLICIES

SIGNIFICANT ACCOUNTING POLICIES	12 Months Ended
	Aug. 31, 2018
SIGNIFICANT ACCOUNTING POLICIES [Text Block]	3. SIGNIFICANT ACCOUNTING POLICIES a. Basis of Presentation The accompanying financial statements have been prepared in accordance with U.S. generally accepted accounting principles. b. Revenue Recognition The Company recognizes revenue from product sales when persuasive evidence of an arrangement exists, title to product and associated risk of loss has passed to the customer, the price is fixed or determinable, collection from the customer is reasonably assured, the Company has no further performance obligation, and returns can be reasonably estimated. c. Cash and Cash Equivalents Cash equivalents comprise certain highly liquid instruments with a maturity of three months or less when purchased. As of August 31, 2018 and 2017, cash and cash equivalents consist of cash only. d. Marketable Securities Marketable securities are classified at fair value through profit (loss). They consist of equities which are all traded in the public markets. Marketable securities are recorded at fair value, with changes to fair value recorded in profit or loss. e. Investments in Affiliated Companies Accounted for Using the Equity Method Investments in equity method investees are accounted for using the equity method based upon the level of ownership and/or the Company’s ability to exercise significant influence over the operating and financial policies of the investee. Investments of this nature are recorded at original cost and adjusted periodically to recognize the Company’s proportionate share of the investees’ net income or losses after the date of investment. When net losses from and investment accounted for under the equity method exceeds its carrying amount, the investment balance is reduced to zero. The Company resumes accounting for the investment under the equity method if the entity subsequently reports net income and the Company’s share of that net income exceed the share of the net losses not recognized during the period the equity method was suspended. Investments are written down only when there is clear evidence that a decline in value that is other than temporary has occurred. When an investment accounted for using the equity method issues its own shares, the subsequent reduction in the Company’s proportionate interest in the investee is reflected in income as a deemed dilution gain or loss on disposition. The Company evaluates its investments in companies accounted for the equity or cost method for impairment when there is evidence or indicators that a decrease in value may be other than temporary. f. Long term investments Other long term investments for which the Company does not have the ability to exercise significant influence and for which there is not a readily determinable market value are accounted for under the cost method of accounting, such that they are recorded at the lower of cost or estimated net realizable value. Management periodically reviews the cost method investments for instances where fair value is less than the carrying amount and the decline in value is determined to be other than temporary. If the decline in value is judged to be other than temporary, the carrying amount of the security is written down to fair value and the resulting loss is charged to operations. g. Mineral Properties Acquisition costs of mineral rights are initially capitalized as incurred while exploration and pre-extraction expenditures are expensed as incurred until such time proven or probable reserves are established for that project. Acquisition costs include cash consideration and the fair market value of shares issued on the acquisition of mineral properties. Expenditures relating to exploration activities are expensed as incurred and expenditures relating to pre-extraction activities are expensed as incurred until such time proven or probable reserves are established for that project, after which subsequent expenditures relating to development activities for that particular project are capitalized as incurred. Where proven and probable reserves have been established, the project’s capitalized expenditures are depleted over proven and probable reserves using the units-of production method upon commencement of production. Where proven and probable reserves have not been established, the project’s capitalized expenditures are depleted over the estimated extraction life using the straight-line method upon commencement of extraction. The Company has not established proven or probable reserves for any of its projects. The carrying values of the mineral rights are assessed for impairment by management on a quarterly basis and as required whenever indicators of impairment exist. An impairment loss is recognized if it is determined that the carrying value is not recoverable and exceeds fair value. h. Lithium Technology The Company has capitalized the cost of the purchase of licensing rights for technology used in the process of recovering and extraction of battery grade lithium carbonate powder from brine solutions as an intangible asset. The licensing agreement has a term of 7 years, with a right of refusal option for an additional ten year period, beginning from the date of a successful bench test. Until a successful bench test is achieved, there is no finite life for this agreement, and it is as of now an intangible asset with an indefinite life. In accordance with ASC 350, the Company has not yet begun to amortize the indefinite life intangible asset, instead testing it for impairment at reporting periods. Aside from the capitalized acquisition cost, all costs to date have been related to research and development of the technology and expensed to profit and loss in accordance with ASC 730. During the year ended August 31, 2018, the agreement, which provided licensing rights was terminated and the related costs were expensed to profit and loss. i. Stock-Based Compensation The Company followed Accounting Standards Codification (“ASC”) 718, “Compensation – Stock Compensation”, to account for its stock options and similar equity instruments issued. Accordingly, compensation costs attributable to stock options or similar equity instruments granted are measured at the fair value at the grant date, and expensed over the expected vesting period. ASC 718 requires excess tax benefits be reported as a financing cash inflow rather than as a reduction of taxes paid. j. Accounting Estimates The preparation of financial statements in conformity with U.S GAAP requires us to make certain estimates, judgments and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Some of the Company’s accounting policies require us to make subjective judgments, often as a result of the need to make estimates of matters that are inherently uncertain. These accounting policies involve critical accounting estimates because they are particularly dependent on estimates and assumptions made by management about matters that are highly uncertain at the time the accounting estimates are made. Although we have used our best estimates based on facts and circumstances available to us at the time, different estimates reasonably could have been used. Changes in the accounting estimates used by the Company are reasonably likely to occur from time to time, which may have a material effect on the presentation of financial condition and results of operations. The Company reviews these estimates, judgments and assumptions periodically and reflect the effects of revisions in the period in which they are deemed to be necessary. We believe that these estimates are reasonable; however, actual results could differ from these estimates. Significant accounting estimates and assumptions are used for, but not limited to: a) The Valuation of Deferred Tax Assets b) Value of Stock Options k. Loss Per Share Loss per share is computed using the weighted average number of shares outstanding during the period. The Company has adopted ASC 220 “Earnings Per Share”. Diluted loss per share is equivalent to basic loss per share because the potential exercise of the equity-based financial instruments was anti-dilutive. l. Foreign Currency Translations The Company’s operations are located in the United States of America and it has offices in Canada. The Company maintains its accounting records in U.S. Dollars, as follows: At the transaction date, each asset, liability, revenue and expense that was acquired or incurred in a foreign currency is translated into U.S. dollars by the using of the exchange rate in effect at that date. At the year end, monetary assets and liabilities are translated at the exchange rate in effect at that date. The resulting foreign exchange gains and losses are included in operations. m. Financial Instruments ASC 820 “Fair Value Measurements and Disclosures” requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 establishes a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used to measure fair value. A financial instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. ASC 820 prioritizes the inputs into three levels that may be used to measure fair value: Level 1 - Quoted prices in active markets for identical assets or liabilities; Level 2 - Inputs other than quoted prices included within Level 1 that are either directly or indirectly observable; and Level 3 - Unobservable inputs that are supported by little or no market activity, therefore requiring an entity to develop its own assumptions about the assumptions that market participants would use in pricing. The Company’s financial instruments consist primarily of cash and cash equivalents, marketable securities, accounts receivable, accounts payable and due to related parties. With the exception of marketable securities, the carrying amounts of these financial instruments approximate their fair values due to their short maturities. The fair value of marketable securities are measured based on quoted prices in active markets. Cash and cash equivalents and marketable securities were in level 1 within the fair value hierarchy. The Company’s operations are in United States of America and Canada, which results in exposure to market risks from changes in foreign currency rates. The financial risk is the risk to the Company’s operations that arise from fluctuations in foreign exchange rates and the degree of volatility of these rates. Currently, the Company does not use derivative instruments to reduce its exposure to foreign currency risk. n. Income Taxes The Company has adopted ASC 740, “Income Taxes”, which requires the Company to recognize deferred tax liabilities and assets for the expected future tax consequences of events that have been recognized in the Company’s financial statements or tax returns using the liability method. Under this method, deferred tax liabilities and assets are determined based on the temporary differences between the financial statement and tax bases of assets and liabilities using enacted tax rates in effect in the year in which the differences are expected to reverse. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the period that includes the enactment date. In addition, a valuation allowance is established to reduce any deferred tax asset for which it is determined that it is more likely than not that some portion of the deferred tax asset will not be realized. o. Long-Lived Assets Impairment In accordance with ASC 360, “Accounting for Impairment or Disposal of Long Lived Assets”, the carrying value of long lived assets are tested for recoverability whenever events or changes in circumstances indicate that its carrying amount may not be recoverable. The Company recognizes impairment when the sum of the expected undiscounted future cash flows is less than the carrying amount of the asset. Impairment losses, if any, are measured as the excess of the carrying amount of the asset over its estimated fair value. p. Asset Retirement Obligations The Company accounts for asset retirement obligations in accordance with the provisions of ASC 410, “Asset Retirement and Environmental Obligations”. ASC 410 requires the Company to record the fair value of an asset retirement obligation as a liability in the period in which it incurs a legal obligation associated with the retirement of tangible long-lived assets that result from the acquisition, construction, development and/or normal use of the assets. The Company does not believe it has any asset retirement obligation as of August 31, 2018 and 2017. q. Comprehensive Income The Company has adopted ASC 220, “Comprehensive Income”, which establishes standards for reporting and display of comprehensive income, its components and accumulated balances. The Company is disclosing this information on its Statement of Stockholders’ Equity. Comprehensive income comprises equity except those transactions resulting from investments by owners and distributions to owners. r. Concentration of credit risk The Company places its cash and cash equivalent with high credit quality financial institution. s. Commitments and Contingencies In accordance with ASC 450-20, Accounting for Contingencies, the Company records accruals for such loss contingencies when it is probable that a liability has been incurred and the amount of loss can be reasonably estimated. In the event that estimates or assumptions prove to differ from actual results, adjustments are made in subsequent periods to reflect more current information. Historically, the Company has not experienced any material claims. t. Research and Development Research and development costs are expensed as incurred. u. New Accounting Pronouncements In June 2018, the FASB issued ASU 2018-07, which simplifies the accounting for nonemployee share-based payment transactions. The amendments specify that Topic 718 applies to all share-based payment transactions in which a grantor acquires goods or services to be used or consumed in a grantor’s own operations by issuing share-based payment awards. The standard will be effective for us in the first quarter of our fiscal year 2020, although early adoption is permitted (but no sooner than the adoption of Topic 606). We do not expect that the adoption of this ASU will have a significant impact on our consolidated financial statements. On November 22, 2017, the FASB issued “ASU 2017-14 — Income Statement—Reporting Comprehensive Income (Topic 220), Revenue Recognition (Topic 605), and Revenue from Contracts with Customers (Topic 606)”. This update amends SEC paragraphs pursuant to the SEC Staff Accounting Bulletin No. 116 and SEC Release No. 33-10403, which bring existing guidance into conformity with Topic 606, Revenue from Contracts with Customers. This update is effective in fiscal years, including interim periods, beginning after December 15, 2017. The adoption of this standard is not expected to have a material impact on the Company´s consolidated financial statements. In August 2016, the FASB issued ASU No. 2016-15 related to the statement of cash flows. This new guidance addresses eight specific cash flow issues with the objective of reducing the existing diversity in practice in how certain cash receipts and cash payments are presented and classified in the statement of cash flows. This update is effective in fiscal years, including interim periods, beginning after December 15, 2017, and early adoption is permitted. The Company has made a preliminary evaluation and expects no material impact to arise from the adoption of this standard on September 1, 2018. In February 2016, Topic 842, Leases was issued to replace the leases requirements in Topic 840, Leases. The main difference between previous GAAP and Topic 842 is the recognition of lease assets and lease liabilities by lessees for those leases classified as operating leases under previous GAAP. A lessee should recognize in the balance sheet a liability to make lease payments (the lease liability) and a right-of-use asset representing its right to use the underlying asset for the lease term. For leases with a term of 12 months or less, a lessee is permitted to make an accounting policy election by class of underlying asset not to recognize lease assets and lease liabilities. If a lessee makes this election, it should recognize lease expense for such leases generally on a straight-line basis over the lease term. The accounting applied by a lessor is largely unchanged from that applied under previous GAAP. Topic 842 will be effective for annual reporting periods beginning after December 15, 2018, including interim periods within those annual periods and is to be retrospectively applied. Earlier application is permitted. The adoption of this standard is not expected to have a significant impact on the Company’s results of operations, financial condition, cash flows, and financial statement disclosures. In May 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers. The new standard provides a five-step approach to be applied to all contracts with customers and also requires expanded disclosures about revenue recognition. The ASU is effective for annual reporting periods beginning after December 15, 2017, including interim periods and is to be retrospectively applied. The adoption of this standard is not expected to have a significant impact on the Company’s results of operations, financial condition, and cash flows.

MARKETABLE SECURITIES

MARKETABLE SECURITIES	12 Months Ended
	Aug. 31, 2018
MARKETABLE SECURITIES [Text Block]	4. MARKETABLE SECURITIES As at August 31, 2018 and 2017, the Company held no marketable securities. During the year ended August 31, 2017, the Company disposed of the balance of 156,500 common shares of Lexaria Corp. with a cost basis of $18,780. The proceeds from the sales of shares were $31,096. Accordingly, a gain of $12,316 was recognized in profit and loss.

LONG TERM INVESTMENTS

LONG TERM INVESTMENTS	12 Months Ended
	Aug. 31, 2018
LONG TERM INVESTMENTS [Text Block]	5. LONG TERM INVESTMENTS Global Solar Water Power Systems Inc. (“GSWPS”) On February 28, 2010, the Company entered into an Asset and Share Purchase Agreement with the Company’s former chief technical officer - Mr. Mark Snyder to acquire up to 20% ownership interest of GSWPS. During the year ended August 31, 2013, based on the management’s assessment of GSWPS’s current operations, the Company decided to write down long-term investment in GSWPS to $1. During the year ended August 31, 2018, based on the management’s assessment of GSWPS’s current operations, the Company decided to write down long-term investment in GSWPS to $nil. Pro Eco Energy USA Ltd. During the year ended August 31, 2008, the Company purchased 900,000 shares in Pro Eco Energy USA Ltd. (“Pro Eco Energy”) for $45,000. During the year ended August 31, 2014, the Company sold its investment in Pro Eco Energy to Western Standard Energy Corp. for $40,000. During the year ended August 31, 2015, 600,000 shares of Pro Eco Energy were returned to the Company and the receivable from Western Standard Energy Corp. was settled. The Company has no significant influence in Pro Eco Energy. During the year ended August 31, 2017, Pro Eco Energy announced it will be closing out the company and the asset was written down to $nil.

MINERAL PROPERTY

MINERAL PROPERTY	12 Months Ended
	Aug. 31, 2018
MINERAL PROPERTY [Text Block]	6. MINERAL PROPERTY During the year ended August 30, 2017 the Company staked lode and placer claims on BLM lands in Esmerelda county Nevada covering approximately 160 Acres subject to adjustment. The Company has a 100% interest in the lands and is only responsible for the yearly maintenance fees to keep its 100% interest. The claims are in good standing until August 31, 2019.

LITHIUM TECHNOLOGY

LITHIUM TECHNOLOGY	12 Months Ended
	Aug. 31, 2018
LITHIUM TECHNOLOGY [Text Block]	7. LITHIUM TECHNOLOGY On August 15, 2016, a binding Letter of Intent (“LOI’) was signed by Enertopia and Genesis Water Technologies, Inc. ("GWT") with regard to the acquisition by Enertopia of the exclusive worldwide licensing rights (the "Licensing Rights") by Enertopia of all of the technology used in the process of recovering and extraction of battery grade lithium carbonate powder Li2CO3 grading 99.5% or higher purity from brine solutions. Upon the execution of this LOI, Enertopia issued 250,000 common shares valued at $12,500 to GWT. On December 6, 2016, and amended on October 9, 2017, Enertopia and GWT signed a Definitive Commercial Agreement with regard to the acquisition by Enertopia of the exclusive licensing rights in the United States of America, Argentina, Bolivia and Chile of all of the technology used in the process of recovering and extraction of battery grade lithium carbonate powder Li2CO3 grading 99.5% or higher purity from brine solutions. On July 4, 2018, the Company provided GWT with a formal notice of termination of the commercialization agreement. Following termination, the Company has no further obligations with respect to the commercialization agreement. As a result, for the year ended August 31, 2018, the Company wrote off capitalized costs of $12,500.

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	12 Months Ended
	Aug. 31, 2018
RELATED PARTY TRANSACTIONS [Text Block]	8. RELATED PARTY TRANSACTIONS For the year ended August 31, 2018, the Company was party to the following related party transactions with key management personnel, which consists of the President, Chief Executive Officer, Chief Financial Officer and directors: • Incurred $42,000 (August 31, 2017: $72,000) to the President of the Company in consulting fees (Note 11(a)). As at August 31, 2018, the accounts payable to the President of the Company was $171,234 (August 31, 2017: $141,035) • Incurred $Nil (August 31, 2017: $62,040) in consulting fees to a company controlled by the former CFO of the Company. • Incurred share based compensation expenses of $43,938 in relation to stock options issued to officers and directors of the Company (August 31, 2017: $58,942). • Incurred $787 (August 31, 2017: $Nil) to a director of the Company. The related party transactions are recorded at the exchange amount established and agreed to between the related parties.

COMMON STOCK

COMMON STOCK	12 Months Ended
	Aug. 31, 2018
COMMON STOCK [Text Block]	9. COMMON STOCK On September 23, 2016, the Company closed the final tranche of a private placement of 3,858,571 units at a price of CAD$0.035 per unit for gross proceeds of CAD$135,050 (equivalent of $100,037). Each unit consists of one common share of the Company and one non-transferable share purchase warrant, each full warrant entitling the holder to purchase one additional common share of the Company for a period of 24 months from the date of issuance, at a purchase price $0.07. A cash finders’ fee of CAD$4,830 and 138,000 full broker warrants that expire September 23, 2018 was paid to Canaccord Genuity and Leede Jones Gable Inc. On October 7, 2016, the Company issued 175,000 shares with a fair value of $7,000 per the definitive agreement signed on May 12, 2016 to purchase a 100% interest in approximately 2,560 acres of placer mining claims in Churchill, Lander and Nye Counties Nevada, USA. Also see Note 7. The value of the shares was capitalized to Mineral Properties. On January 20, 2017, the Company closed the first tranche of a private placement of 1,000,000 units at a price of CAD$0.04 per unit for gross proceeds of CAD$40,000 (equivalent of $29,630). Each unit consists of one common share of the Company and one non-transferable share purchase warrant, each full warrant entitling the holder to purchase one additional common share of the Company for a period of 24 months from the date of issuance, at a purchase price of $0.06. A cash finders’ fee of CAD$800 and 20,000 full broker warrants that expire January 20, 2019 was paid to Leede Jones Gable Inc. On February 28, 2017, the Company closed the first tranche of a private placement of 4,250,000 units at a price of CAD$0.04 per unit for gross proceeds of CAD$170,000 (equivalent of $125,926). Each unit consists of one common share of the Company and one non-transferable share purchase warrant, each full warrant entitling the holder to purchase one additional common share of the Company for a period of 24 months from the date of issuance, at a purchase price of $0.06. A cash finders’ fee of CAD$11,100 and 227,500 full broker warrants that expire February 28, 2019 was paid to Leede Jones Gable Inc., Canaccord Genuity and Duncan McKay. On April 21, 2017, the Company issued 95,500 shares for gross proceeds of $5,685 from the exercise of warrants of previous financings at $0.05 and $0.07. On April 30, 2017, the Company issued 166,500 shares for gross proceeds of $11,655 from the exercise of warrants from a previous financing at $0.07. On April 30, 2017, the Company closed the final tranche of a private placement of 3,224,000 units at a price of CAD$0.09 per unit for gross proceeds of CAD$290,160 (equivalent of $214,933). Each unit consists of one common share of the Company and one non-transferable share purchase warrant, each full warrant entitling the holder to purchase one additional common share of the Company for a period of 24 months from the date of issuance, at a purchase price of $0.12. A cash finders’ fee of CAD$20,736 and 230,400 full broker warrants that expire April 28, 2019 was paid to Leede Jones Gable and Canaccord Genuity. On November 1, 2017, the Company closed the first tranche of a private placement of 2,600,000 units at a price of CAD$0.05 per unit for gross proceeds of CAD$130,000 (equivalent of $101,198). Each unit consists of one common share of the Company and one non-transferable share purchase warrant, each full warrant entitling the holder to purchase one additional common share of the Company for a period of 24 months from the date of issuance, at a purchase price of $0.06. On December 8, 2017, the Company closed the second tranche of a private placement of 3,954,000 units at a price of CAD$0.05 per unit for gross proceeds of CAD$197,700 (equivalent of $154,397). Each unit consists of one common share of the Company and one non-transferable share purchase warrant, each full warrant entitling the holder to purchase one additional common share of the Company for a period of 24 months from the date of issuance, at a purchase price of $0.06. A cash finder’s fee of CAD$12,770 (equivalent of $9,938) and 230,400 broker warrants was paid to a third party. The broker warrants have the same terms as the warrants issued as part of the unit offering. On December 8, 2017, the Company issued 240,000 shares for gross proceeds of $12,000 from the exercise of stock options at $0.05. On January 12, 2018, the Company closed the final tranche of a private placement of 1,611,000 units at a price of CAD$0.05 per unit for gross proceeds of CAD$80,550 (equivalent of $64,371). Each unit consists of one common share of the Company and one non-transferable share purchase warrant, each full warrant entitling the holder to purchase one additional common share of the Company for a period of 24 months from the date of issuance, at a purchase price of $0.06. A cash finder’s fee of CAD$3,880 (equivalent of $3,103) and 77,600 broker warrants was paid to a third party. The broker warrants have the same terms as the warrants issued as part of the unit offering. On February 2, 2018, the Company issued 50,000 shares for gross proceeds of $3,500 from the exercise of warrants at $0.07. On May 11, 2018, the Company issued 200,000 shares for gross proceeds of $12,000 from the exercise of stock options at $0.06. On May 11, 2018, the Company closed the first tranche of a private placement of 1,746,900 units at a price of CAD$0.06 per unit for gross proceeds of CAD$104,814 (equivalent of $81,987). Each unit consists of one common share of the Company and one non-transferable share purchase warrant, each full warrant entitling the holder to purchase one additional common share of the Company for a period of 24 months from the date of issuance, at a purchase price of $0.075. A cash finders’ fee of CAD$9,281 (equivalent of $7,258) and 144,690 full broker warrants that expire May 11, 2020 was paid to third parties. The broker warrants have the same terms as the warrants issued as part of the unit offering. On May 25, 2018, the Company closed the final tranche of a private placement of 2,470,000 units at a price of CAD$0.06 per unit for gross proceeds of CAD$148,200 (equivalent of $114,822). Each unit consists of one common share of the Company and one non-transferable share purchase warrant, each full warrant entitling the holder to purchase one additional common share of the Company for a period of 24 months from the date of issuance, at a purchase price of $0.075. A cash finders’ fee of CAD$5,820 (equivalent of $4,488) and 70,000 full broker warrants that expire May 25, 2020 was paid to third parties. The broker warrants have the same terms as the warrants issued as part of the unit offering. On August 31, 2018, the Company closed the first tranche of a private placement of 4,400,000 units at a price of CAD$0.03 per unit for gross proceeds of CAD$132,000 (equivalent of $101,111). Each unit consists of one common share of the Company and one non-transferable share purchase warrant, each full warrant entitling the holder to purchase one additional common share of the Company for a period of 36 months from the date of issuance, at a purchase price of $0.05. A cash finders’ fee of CAD$12,000 (equivalent of $9,192) and 400,000 full broker warrants that expire August 31, 2021 was paid to third parties. The broker warrants have the same terms as the warrants issued as part of the unit offering. On August 31, 2018, the Company issued 170,000 shares for gross proceeds of $9,000 from the exercise of 50,000 stock options at $0.06 and 120,000 stock options at $0.05 respectively. As at August 31, 2018 the Company had 119,739,931 shares issued and outstanding and as at August 31, 2017, the Company had 102,298,031 shares issued and outstanding.

STOCK OPTIONS AND WARRANTS

STOCK OPTIONS AND WARRANTS	12 Months Ended
	Aug. 31, 2018
STOCK OPTIONS AND WARRANTS [Text Block]	10. STOCK OPTIONS AND WARRANTS Stock Options On July 15, 2014, the shareholders approved and adopted at the Annual General Meeting the Company’s 2014 Stock Option Plan. On April 14, 2011, the shareholders approved and adopted at the Annual General Meeting to consolidate the Company’s 2007 Equity compensation plan and the Company’s 2010 Equity Compensation Plan into a new Company 2011 Stock Option Plan. The purpose of these Plans is to advance the interests of the Corporation, through the grant of Options, by providing an incentive mechanism to foster the interest of eligible persons in the success of the Corporation and its affiliates; encouraging eligible persons to remain with the Corporation or its affiliates; and attracting new Directors, Officers, Employees and Consultants. On September 19, 2016, the Company granted 800,000 stock options to consultant of the Company with an exercise price of $0.07 vested immediately, expiring September 19, 2021. On January 20, 2017, the Company granted 1,535,000 stock options to directors, officers and consultant of the Company with an exercise price of $0.07 vested immediately, expiring January 20, 2022. On January 31, 2017, the Company granted 1,500,000 stock options to consultant of the Company with an exercise price of $0.07 vested immediately, expiring January 31, 2022. On May 2, 2017, the Company granted 500,000 stock options to consultant of the Company with an exercise price of $0.10, vested immediately, expiring May 2, 2022. On November 1, 2017, the Company granted 800,000 stock options to a director and consultant of the Company with an exercise price of $0.05, expiring November 2, 2022. On May 11, 2018, the Company granted 535,000 stock options to a director and consultant of the Company with an exercise price of $0.06, expiring May 11, 2023. On May 22, 2018, the Company granted 550,000 stock options to consultants of the Company with an exercise price of $0.07, expiring May 22, 2023. For the year ended August 31, 2018, the Company recorded $89,596 (August 31, 2017: $227,428) stock based compensation expense. A summary of the changes in stock options for the year ended August 31, 2018 is presented below: Options Outstanding Weighted Average Number of Shares Exercise Price Balance, August 31, 2016 3,210,000 $ 0.07 Cancelled (250,000 ) 0.06 Granted 4,335,000 0.07 Balance, August 31, 2017 7,295,000 $ 0.07 Granted 1,885,000 0.06 Exercised (610,000 ) 0.05 Balance, August 31, 2018 8,570,000 $ 0.07 The fair value of options granted has been estimated as of the date of the grant by using the Black-Scholes option pricing model with the following assumptions: August 31, 2018 August 31, 2017 Expected volatility 204% 182%-232% Risk-free interest rate 1.93% 1.22%- 1.95% Expected life 5.00 years 5.00 years Dividend yield 0.00% 0.00% Estimated fair value per option $0.05 $0.05 -$0.09 The Company has the following options outstanding and exercisable. August 31, 2018 Options outstanding and exercisable Number Remaining Exercise prices of shares contractual life $0.07 550,000 4.73 years $0.06 535,000 4.70 years $0.05 800,000 4.16 years $0.10 500,000 3.67 years $0.07 1,500,000 3.42 years $0.07 1,535,000 3.39 years $0.07 800,000 3.05 years $0.05 1,100,000 2.15 years $0.10 1,000,000 1.18 years $0.06 250,000 0.18 years 1 8,570,000 2.88 years 1. 250,000 options expired unexercised subsequent to August 31, 2018 August 31, 2017 Options outstanding and exercisable Number Remaining Exercise prices of shares contractual life $0.10 500,000 4.67 years $0.07 1,500,000 4.42 years $0.07 1,535,000 4.39 years $0.07 800,000 4.05 years $0.05 1,460,000 3.15 years $0.10 1,000,000 2.18 years $0.06 500,000 1.18 years 7,295,000 3.43 years The aggregate intrinsic value for options vested and total options as at August 31, 2018 and 2017 is $Nil. Warrants On February 28, 2017, the Company signed a Letter of Engagement with Adam Mogil and issued 1,000,000 warrant options to convert to 1,000,000 common shares to Adam Mogil to provide corporate services. The warrants have an exercise price of $0.09 and expire August 28, 2017. The fair value of the warrants granted has been estimated as of the date of the grant by using the Black-Scholes option pricing model with the following assumptions: expected volatility: 182%, risk-free interest rate: 1.22%, expected life: 0.50 years, dividend yield: 0.00% . The Company has recorded $29,168 in stock based compensation expense related to these warrants in the year ended August 31, 2017. On April 21, 2017, the Company issued 95,500 shares for gross proceeds of $5,685 from the exercise of warrants of previous financings at $0.05 and $0.07. On April 30, 2017, the Company issued 166,500 shares for gross proceeds of $11,655 from the exercise of warrants from a previous financing at $0.07. During the year ended August 31, 2017, the Company issued 12,332,571 warrants attached to units issued in multiple private placements, see Note 9 for disclosure of individual amounts and terms of warrants by private placement. In addition, the Company issued 615,900 brokers warrants in connection with these private placements, also disclosed in Note 9. The fair value of the brokers warrants was $33,213 (2016 - $Nil), recorded as share issuance costs off-setting the gross proceeds of private placements in additional-paid-in-capital, and was calculated using the Black Scholes option pricing model, with the following weighted average assumptions: expected volatility 168%, risk-free interest rate: 1.14%, expected life: 2 years, dividend yield: 0.00% . During the year ended August 31, 2018, the Company issued 16,781,900 warrants attached to units in private placements and 922,690 broker warrants in connection with the private placements, see Note 9 for disclosure of the terms of the warrants. The fair value of the brokers warrants was $27,791, recorded as share issuance costs off-setting the gross proceeds of private placements in additional-paid-in-capital, and was calculated using the Black Scholes option pricing model, with the following weighted average assumptions: expected volatility 152%, risk-free interest rate: 2.10%, expected life: 2.43 years, dividend yield: 0.00% . A summary of warrants as at August 31, 2018 and August 31, 2017 is as follows: Warrant Outstanding Weighted Average Number of warrants Exercise Price Balance, August 31, 2016 29,412,139 $ 0.09 Expired (3,906,800 ) 0.10 Exercised (262,000 ) 0.07 Issued 13,948,471 0.08 Balance, August 31, 2017 39,191,810 $ 0.09 Expired (16,107,340 ) 0.12 Issued 17,704,590 0.06 Exercised (50,000 ) 0.07 Balance, August 31, 2018 40,739,060 $ 0.06 Number Exercise Expiry Outstanding 1 Price Date 4,800,000 $0.050 August 31, 2021 2,540,000 $0.075 May 25, 2020 1,891,590 $0.075 May 11, 2020 1,688,600 $0.060 January 12, 2020 4,184,400 $0.060 December 8, 2019 2,600,000 $0.060 November 1, 2019 3,253,333 $0.050 and $0.10 after 18 months June 8, 2019 6,882,666 $0.050 and $0.10 after 18 months May 20, 2019 3,454,400 $0.120 April 29, 2019 4,477,500 $0.060 February 28, 2019 1,020,000 $0.060 January 20, 2019 3,946,571 $0.070 September 23, 2018 2 40,739,060 1. Each warrant entitles a holder to purchase one common share. 2. 3,946,571 warrants expired unexercised subsequent to August 31, 2018

COMMITMENTS - OTHER

COMMITMENTS - OTHER	12 Months Ended
	Aug. 31, 2018
COMMITMENTS - OTHER [Text Block]	1 1. COMMITMENTS - OTHER (a) The Company has a consulting agreement with the President of the Company for corporate administration and consulting services for $3,500 per month plus goods and services tax (“GST”) on a continuing basis.

INCOME TAXES

INCOME TAXES	12 Months Ended
	Aug. 31, 2018
INCOME TAXES [Text Block]	12. INCOME TAXES The following table reconciles the income tax benefit at the U.S. Federal statutory income tax rates to income tax benefit at the Company’s effective tax rates at August 31, 2018 and 2017: August 30, August 30, 2018 2017 Loss before taxes $ (650,055 ) $ (801,166 ) Statutory tax rate 25.3% 34% Expected income tax recovery (164,680 ) (272,396 ) Non-deductible items 22,698 77,326 Change in enacted rates and other 1,618,859 (40,132 ) Adjustment to prior years provision versus statutory tax returns and expiry of non-capital losses (65,410 ) - Share issuance costs - (17,769 ) Change in valuation allowance (1,411,467 ) 252,971 Income tax expense (recovery) $ - $ - In December 2017, the United States Government proposed changes to the Federal corporate income tax rate to reduce the rate from 34% to 21% effective January 1, 2018 and onwards. This change in tax rate was substantively enacted on December 22, 2017. The relevant deferred tax balances have been remeasured to reflect the decrease in the Company's Federal income tax rate from 34% to 21%. Deferred taxes reflect the tax effects of temporary differences between the carrying amount of assets and liabilities for financial reporting purposes. Deferred tax assets (liabilities) at August 31, 2018 and 2017 are comprised of the following: August 30, August 30, 2018 2017 Net operating loss carry forwards $ 2,722,136 $ 4,110,965 Marketable securities 5,698 9,225 Financing costs 7,253 15,839 Intangible assets 4,725 - Mineral property 20,108 32,555 Capital loss carry forwards 4,526 7,328 2,764,446 4,175,912 Valuation allowance 2,764,446 4,175,912 Deferred tax assets (liabilities) $ - $ - The Company has net operating loss carry forwards of approximately $12,963,000 which may be carried forward to apply against future taxable income for US tax purposes, subject to the final determination by the taxation authority, expiring in the following years. Future tax assets have not been recognized because it is not probable that future taxable profit will be available against which the Company can utilize the benefits therefrom.

SEGMENTED INFORMATION

SEGMENTED INFORMATION	12 Months Ended
	Aug. 31, 2018
SEGMENTED INFORMATION [Text Block]	13. SEGMENTED INFORMATION As at August 31, 2018 and August 31, 2017, the Company is operating its business in one reportable segment: natural resource acquisitions.

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	12 Months Ended
	Aug. 31, 2018
SUBSEQUENT EVENTS [Text Block]	14. SUBSEQUENT EVENTS On September 21, 2018, the Company closed the final tranche of a private placement of 2,225,000 units at a price of CAD$0.03 per unit for gross proceeds of CAD$66,750. Each unit consists of one common share of the Company and one non-transferable share purchase warrant, each full warrant entitling the holder to purchase one additional common share of the Company for a period of 36 months from the date of issuance, at a purchase price of $0.05. A cash finders’ fee of CAD$6,075 and 202,500 full broker warrants that expire September 21, 2021 was paid to third parties. The broker warrants have the same terms as the warrants issued as part of the unit offering.

Summary of Significant Accounti

Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Aug. 31, 2018
Basis of Presentation [Policy Text Block]	a. Basis of Presentation The accompanying financial statements have been prepared in accordance with U.S. generally accepted accounting principles.
Revenue Recognition [Policy Text Block]	b. Revenue Recognition The Company recognizes revenue from product sales when persuasive evidence of an arrangement exists, title to product and associated risk of loss has passed to the customer, the price is fixed or determinable, collection from the customer is reasonably assured, the Company has no further performance obligation, and returns can be reasonably estimated.
Cash and Cash Equivalents [Policy Text Block]	c. Cash and Cash Equivalents Cash equivalents comprise certain highly liquid instruments with a maturity of three months or less when purchased. As of August 31, 2018 and 2017, cash and cash equivalents consist of cash only.
Marketable Securities [Policy Text Block]	d. Marketable Securities Marketable securities are classified at fair value through profit (loss). They consist of equities which are all traded in the public markets. Marketable securities are recorded at fair value, with changes to fair value recorded in profit or loss.
Investments in Affiliated Companies Accounted for Using the Equity Method [Policy Text Block]	e. Investments in Affiliated Companies Accounted for Using the Equity Method Investments in equity method investees are accounted for using the equity method based upon the level of ownership and/or the Company’s ability to exercise significant influence over the operating and financial policies of the investee. Investments of this nature are recorded at original cost and adjusted periodically to recognize the Company’s proportionate share of the investees’ net income or losses after the date of investment. When net losses from and investment accounted for under the equity method exceeds its carrying amount, the investment balance is reduced to zero. The Company resumes accounting for the investment under the equity method if the entity subsequently reports net income and the Company’s share of that net income exceed the share of the net losses not recognized during the period the equity method was suspended. Investments are written down only when there is clear evidence that a decline in value that is other than temporary has occurred. When an investment accounted for using the equity method issues its own shares, the subsequent reduction in the Company’s proportionate interest in the investee is reflected in income as a deemed dilution gain or loss on disposition. The Company evaluates its investments in companies accounted for the equity or cost method for impairment when there is evidence or indicators that a decrease in value may be other than temporary.
Long term investments [Policy Text Block]	f. Long term investments Other long term investments for which the Company does not have the ability to exercise significant influence and for which there is not a readily determinable market value are accounted for under the cost method of accounting, such that they are recorded at the lower of cost or estimated net realizable value. Management periodically reviews the cost method investments for instances where fair value is less than the carrying amount and the decline in value is determined to be other than temporary. If the decline in value is judged to be other than temporary, the carrying amount of the security is written down to fair value and the resulting loss is charged to operations.
Mineral Properties [Policy Text Block]	g. Mineral Properties Acquisition costs of mineral rights are initially capitalized as incurred while exploration and pre-extraction expenditures are expensed as incurred until such time proven or probable reserves are established for that project. Acquisition costs include cash consideration and the fair market value of shares issued on the acquisition of mineral properties. Expenditures relating to exploration activities are expensed as incurred and expenditures relating to pre-extraction activities are expensed as incurred until such time proven or probable reserves are established for that project, after which subsequent expenditures relating to development activities for that particular project are capitalized as incurred. Where proven and probable reserves have been established, the project’s capitalized expenditures are depleted over proven and probable reserves using the units-of production method upon commencement of production. Where proven and probable reserves have not been established, the project’s capitalized expenditures are depleted over the estimated extraction life using the straight-line method upon commencement of extraction. The Company has not established proven or probable reserves for any of its projects. The carrying values of the mineral rights are assessed for impairment by management on a quarterly basis and as required whenever indicators of impairment exist. An impairment loss is recognized if it is determined that the carrying value is not recoverable and exceeds fair value.
Lithium Technology [Policy Text Block]	h. Lithium Technology The Company has capitalized the cost of the purchase of licensing rights for technology used in the process of recovering and extraction of battery grade lithium carbonate powder from brine solutions as an intangible asset. The licensing agreement has a term of 7 years, with a right of refusal option for an additional ten year period, beginning from the date of a successful bench test. Until a successful bench test is achieved, there is no finite life for this agreement, and it is as of now an intangible asset with an indefinite life. In accordance with ASC 350, the Company has not yet begun to amortize the indefinite life intangible asset, instead testing it for impairment at reporting periods. Aside from the capitalized acquisition cost, all costs to date have been related to research and development of the technology and expensed to profit and loss in accordance with ASC 730. During the year ended August 31, 2018, the agreement, which provided licensing rights was terminated and the related costs were expensed to profit and loss.
Stock-Based Compensation [Policy Text Block]	i. Stock-Based Compensation The Company followed Accounting Standards Codification (“ASC”) 718, “Compensation – Stock Compensation”, to account for its stock options and similar equity instruments issued. Accordingly, compensation costs attributable to stock options or similar equity instruments granted are measured at the fair value at the grant date, and expensed over the expected vesting period. ASC 718 requires excess tax benefits be reported as a financing cash inflow rather than as a reduction of taxes paid.
Accounting Estimates [Policy Text Block]	j. Accounting Estimates The preparation of financial statements in conformity with U.S GAAP requires us to make certain estimates, judgments and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Some of the Company’s accounting policies require us to make subjective judgments, often as a result of the need to make estimates of matters that are inherently uncertain. These accounting policies involve critical accounting estimates because they are particularly dependent on estimates and assumptions made by management about matters that are highly uncertain at the time the accounting estimates are made. Although we have used our best estimates based on facts and circumstances available to us at the time, different estimates reasonably could have been used. Changes in the accounting estimates used by the Company are reasonably likely to occur from time to time, which may have a material effect on the presentation of financial condition and results of operations. The Company reviews these estimates, judgments and assumptions periodically and reflect the effects of revisions in the period in which they are deemed to be necessary. We believe that these estimates are reasonable; however, actual results could differ from these estimates. Significant accounting estimates and assumptions are used for, but not limited to: a) The Valuation of Deferred Tax Assets b) Value of Stock Options
Loss Per Share [Policy Text Block]	k. Loss Per Share Loss per share is computed using the weighted average number of shares outstanding during the period. The Company has adopted ASC 220 “Earnings Per Share”. Diluted loss per share is equivalent to basic loss per share because the potential exercise of the equity-based financial instruments was anti-dilutive.
Foreign Currency Translations [Policy Text Block]	l. Foreign Currency Translations The Company’s operations are located in the United States of America and it has offices in Canada. The Company maintains its accounting records in U.S. Dollars, as follows: At the transaction date, each asset, liability, revenue and expense that was acquired or incurred in a foreign currency is translated into U.S. dollars by the using of the exchange rate in effect at that date. At the year end, monetary assets and liabilities are translated at the exchange rate in effect at that date. The resulting foreign exchange gains and losses are included in operations.
Financial Instruments [Policy Text Block]	m. Financial Instruments ASC 820 “Fair Value Measurements and Disclosures” requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 establishes a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used to measure fair value. A financial instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. ASC 820 prioritizes the inputs into three levels that may be used to measure fair value: Level 1 - Quoted prices in active markets for identical assets or liabilities; Level 2 - Inputs other than quoted prices included within Level 1 that are either directly or indirectly observable; and Level 3 - Unobservable inputs that are supported by little or no market activity, therefore requiring an entity to develop its own assumptions about the assumptions that market participants would use in pricing. The Company’s financial instruments consist primarily of cash and cash equivalents, marketable securities, accounts receivable, accounts payable and due to related parties. With the exception of marketable securities, the carrying amounts of these financial instruments approximate their fair values due to their short maturities. The fair value of marketable securities are measured based on quoted prices in active markets. Cash and cash equivalents and marketable securities were in level 1 within the fair value hierarchy. The Company’s operations are in United States of America and Canada, which results in exposure to market risks from changes in foreign currency rates. The financial risk is the risk to the Company’s operations that arise from fluctuations in foreign exchange rates and the degree of volatility of these rates. Currently, the Company does not use derivative instruments to reduce its exposure to foreign currency risk.
Income Taxes [Policy Text Block]	n. Income Taxes The Company has adopted ASC 740, “Income Taxes”, which requires the Company to recognize deferred tax liabilities and assets for the expected future tax consequences of events that have been recognized in the Company’s financial statements or tax returns using the liability method. Under this method, deferred tax liabilities and assets are determined based on the temporary differences between the financial statement and tax bases of assets and liabilities using enacted tax rates in effect in the year in which the differences are expected to reverse. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the period that includes the enactment date. In addition, a valuation allowance is established to reduce any deferred tax asset for which it is determined that it is more likely than not that some portion of the deferred tax asset will not be realized.
Long-Lived Assets Impairment [Policy Text Block]	o. Long-Lived Assets Impairment In accordance with ASC 360, “Accounting for Impairment or Disposal of Long Lived Assets”, the carrying value of long lived assets are tested for recoverability whenever events or changes in circumstances indicate that its carrying amount may not be recoverable. The Company recognizes impairment when the sum of the expected undiscounted future cash flows is less than the carrying amount of the asset. Impairment losses, if any, are measured as the excess of the carrying amount of the asset over its estimated fair value.
Asset Retirement Obligations [Policy Text Block]	p. Asset Retirement Obligations The Company accounts for asset retirement obligations in accordance with the provisions of ASC 410, “Asset Retirement and Environmental Obligations”. ASC 410 requires the Company to record the fair value of an asset retirement obligation as a liability in the period in which it incurs a legal obligation associated with the retirement of tangible long-lived assets that result from the acquisition, construction, development and/or normal use of the assets. The Company does not believe it has any asset retirement obligation as of August 31, 2018 and 2017.
Comprehensive Income [Policy Text Block]	q. Comprehensive Income The Company has adopted ASC 220, “Comprehensive Income”, which establishes standards for reporting and display of comprehensive income, its components and accumulated balances. The Company is disclosing this information on its Statement of Stockholders’ Equity. Comprehensive income comprises equity except those transactions resulting from investments by owners and distributions to owners.
Concentration of credit risk [Policy Text Block]	r. Concentration of credit risk The Company places its cash and cash equivalent with high credit quality financial institution.
Commitments and Contingencies [Policy Text Block]	s. Commitments and Contingencies In accordance with ASC 450-20, Accounting for Contingencies, the Company records accruals for such loss contingencies when it is probable that a liability has been incurred and the amount of loss can be reasonably estimated. In the event that estimates or assumptions prove to differ from actual results, adjustments are made in subsequent periods to reflect more current information. Historically, the Company has not experienced any material claims.
Research and Development [Policy Text Block]	t. Research and Development Research and development costs are expensed as incurred.
New Accounting Pronouncements [Policy Text Block]	u. New Accounting Pronouncements In June 2018, the FASB issued ASU 2018-07, which simplifies the accounting for nonemployee share-based payment transactions. The amendments specify that Topic 718 applies to all share-based payment transactions in which a grantor acquires goods or services to be used or consumed in a grantor’s own operations by issuing share-based payment awards. The standard will be effective for us in the first quarter of our fiscal year 2020, although early adoption is permitted (but no sooner than the adoption of Topic 606). We do not expect that the adoption of this ASU will have a significant impact on our consolidated financial statements. On November 22, 2017, the FASB issued “ASU 2017-14 — Income Statement—Reporting Comprehensive Income (Topic 220), Revenue Recognition (Topic 605), and Revenue from Contracts with Customers (Topic 606)”. This update amends SEC paragraphs pursuant to the SEC Staff Accounting Bulletin No. 116 and SEC Release No. 33-10403, which bring existing guidance into conformity with Topic 606, Revenue from Contracts with Customers. This update is effective in fiscal years, including interim periods, beginning after December 15, 2017. The adoption of this standard is not expected to have a material impact on the Company´s consolidated financial statements. In August 2016, the FASB issued ASU No. 2016-15 related to the statement of cash flows. This new guidance addresses eight specific cash flow issues with the objective of reducing the existing diversity in practice in how certain cash receipts and cash payments are presented and classified in the statement of cash flows. This update is effective in fiscal years, including interim periods, beginning after December 15, 2017, and early adoption is permitted. The Company has made a preliminary evaluation and expects no material impact to arise from the adoption of this standard on September 1, 2018. In February 2016, Topic 842, Leases was issued to replace the leases requirements in Topic 840, Leases. The main difference between previous GAAP and Topic 842 is the recognition of lease assets and lease liabilities by lessees for those leases classified as operating leases under previous GAAP. A lessee should recognize in the balance sheet a liability to make lease payments (the lease liability) and a right-of-use asset representing its right to use the underlying asset for the lease term. For leases with a term of 12 months or less, a lessee is permitted to make an accounting policy election by class of underlying asset not to recognize lease assets and lease liabilities. If a lessee makes this election, it should recognize lease expense for such leases generally on a straight-line basis over the lease term. The accounting applied by a lessor is largely unchanged from that applied under previous GAAP. Topic 842 will be effective for annual reporting periods beginning after December 15, 2018, including interim periods within those annual periods and is to be retrospectively applied. Earlier application is permitted. The adoption of this standard is not expected to have a significant impact on the Company’s results of operations, financial condition, cash flows, and financial statement disclosures. In May 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers. The new standard provides a five-step approach to be applied to all contracts with customers and also requires expanded disclosures about revenue recognition. The ASU is effective for annual reporting periods beginning after December 15, 2017, including interim periods and is to be retrospectively applied. The adoption of this standard is not expected to have a significant impact on the Company’s results of operations, financial condition, and cash flows.

STOCK OPTIONS AND WARRANTS (Tab

STOCK OPTIONS AND WARRANTS (Tables)	12 Months Ended
	Aug. 31, 2018	Aug. 31, 2017
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]	Options Outstanding Weighted Average Number of Shares Exercise Price Balance, August 31, 2016 3,210,000 $ 0.07 Cancelled (250,000 ) 0.06 Granted 4,335,000 0.07 Balance, August 31, 2017 7,295,000 $ 0.07 Granted 1,885,000 0.06 Exercised (610,000 ) 0.05 Balance, August 31, 2018 8,570,000 $ 0.07
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]	August 31, 2018 August 31, 2017 Expected volatility 204% 182%-232% Risk-free interest rate 1.93% 1.22%- 1.95% Expected life 5.00 years 5.00 years Dividend yield 0.00% 0.00% Estimated fair value per option $0.05 $0.05 -$0.09
Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block]	August 31, 2018 Options outstanding and exercisable Number Remaining Exercise prices of shares contractual life $0.07 550,000 4.73 years $0.06 535,000 4.70 years $0.05 800,000 4.16 years $0.10 500,000 3.67 years $0.07 1,500,000 3.42 years $0.07 1,535,000 3.39 years $0.07 800,000 3.05 years $0.05 1,100,000 2.15 years $0.10 1,000,000 1.18 years $0.06 250,000 0.18 years 1 8,570,000 2.88 years	August 31, 2017 Options outstanding and exercisable Number Remaining Exercise prices of shares contractual life $0.10 500,000 4.67 years $0.07 1,500,000 4.42 years $0.07 1,535,000 4.39 years $0.07 800,000 4.05 years $0.05 1,460,000 3.15 years $0.10 1,000,000 2.18 years $0.06 500,000 1.18 years 7,295,000 3.43 years
Schedule of Stockholders' Equity Note, Warrants or Rights, Activity [Table Text Block]	Warrant Outstanding Weighted Average Number of warrants Exercise Price Balance, August 31, 2016 29,412,139 $ 0.09 Expired (3,906,800 ) 0.10 Exercised (262,000 ) 0.07 Issued 13,948,471 0.08 Balance, August 31, 2017 39,191,810 $ 0.09 Expired (16,107,340 ) 0.12 Issued 17,704,590 0.06 Exercised (50,000 ) 0.07 Balance, August 31, 2018 40,739,060 $ 0.06
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]	Number Exercise Expiry Outstanding 1 Price Date 4,800,000 $0.050 August 31, 2021 2,540,000 $0.075 May 25, 2020 1,891,590 $0.075 May 11, 2020 1,688,600 $0.060 January 12, 2020 4,184,400 $0.060 December 8, 2019 2,600,000 $0.060 November 1, 2019 3,253,333 $0.050 and $0.10 after 18 months June 8, 2019 6,882,666 $0.050 and $0.10 after 18 months May 20, 2019 3,454,400 $0.120 April 29, 2019 4,477,500 $0.060 February 28, 2019 1,020,000 $0.060 January 20, 2019 3,946,571 $0.070 September 23, 2018 2 40,739,060

INCOME TAXES (Tables)

INCOME TAXES (Tables)	12 Months Ended
	Aug. 31, 2018
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]	August 30, August 30, 2018 2017 Loss before taxes $ (650,055 ) $ (801,166 ) Statutory tax rate 25.3% 34% Expected income tax recovery (164,680 ) (272,396 ) Non-deductible items 22,698 77,326 Change in enacted rates and other 1,618,859 (40,132 ) Adjustment to prior years provision versus statutory tax returns and expiry of non-capital losses (65,410 ) - Share issuance costs - (17,769 ) Change in valuation allowance (1,411,467 ) 252,971 Income tax expense (recovery) $ - $ -
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]	August 30, August 30, 2018 2017 Net operating loss carry forwards $ 2,722,136 $ 4,110,965 Marketable securities 5,698 9,225 Financing costs 7,253 15,839 Intangible assets 4,725 - Mineral property 20,108 32,555 Capital loss carry forwards 4,526 7,328 2,764,446 4,175,912 Valuation allowance 2,764,446 4,175,912 Deferred tax assets (liabilities) $ - $ -

GOING CONCERN UNCERTAINTY (Narr

GOING CONCERN UNCERTAINTY (Narrative) (Details) - USD ($)	12 Months Ended
	Aug. 31, 2018	Aug. 31, 2017
Working Capital Deficit	$ 177,580	$ 250,029
Net Income (Loss)	650,055	$ 801,166
Cumulative Losses	$ 13,891,818

MARKETABLE SECURITIES (Narrativ

MARKETABLE SECURITIES (Narrative) (Details) - USD ($)	12 Months Ended
	Aug. 31, 2018	Aug. 31, 2017
Marketable securities, shares, sold		156,500
Marketable securities, value at cost, sold		$ 18,780
Proceeds from Sale and Maturity of Marketable Securities	$ 0	31,096
Marketable Securities, Realized Gain (Loss)		$ 12,316

LONG TERM INVESTMENTS (Narrativ

LONG TERM INVESTMENTS (Narrative) (Details) - USD ($)	12 Months Ended
	Aug. 31, 2015	Aug. 31, 2014	Aug. 31, 2018	Aug. 31, 2017	Aug. 31, 2013	Feb. 28, 2010	Aug. 31, 2008
GSWPS [Member]
Investment Owned, Ownership Interest						20.00%
Long term investments			$ 0		$ 1
Pro Eco Energy [Member]
Investment Owned, Balance, Shares							900,000
Long term investments				$ 0			$ 45,000
Proceeds from Sale of Long-term Investments		$ 40,000
Stock Redeemed or Called During Period, Value	$ 600,000

MINERAL PROPERTY (Narrative) (D

MINERAL PROPERTY (Narrative) (Details)	12 Months Ended
	Aug. 31, 2018
Percentage of Land Rights Interest	100.00%

LITHIUM TECHNOLOGY (Narrative)

LITHIUM TECHNOLOGY (Narrative) (Details) - USD ($)	Aug. 15, 2016	Aug. 31, 2018
Stock Issued During Period, Shares, Purchase of Assets	250,000
Stock Issued During Period, Value, Purchase of Assets	$ 12,500
Capitalized costs written off		$ 12,500

RELATED PARTY TRANSACTIONS (Nar

RELATED PARTY TRANSACTIONS (Narrative) (Details)	12 Months Ended
	Aug. 31, 2018USD ($)	Aug. 31, 2018CAD ($)	Aug. 31, 2017USD ($)	Aug. 31, 2017CAD ($)
President [Member]
Consulting Fees	$ 42,000		$ 72,000
Due to the President	171,234		141,035
Chief Financial Officer [Member]
Consulting Fees		$ 0		$ 62,040
Director [Member]
Share based Compensation to Director	43,938		58,942
Related Party Transaction, Expenses from Transactions with Related Party	$ 787		$ 0

COMMON STOCK (Narrative) (Detai

COMMON STOCK (Narrative) (Details)	May 11, 2018USD ($)$ / sharesshares	May 11, 2018CAD ($)$ / sharesshares	Feb. 02, 2018USD ($)$ / sharesshares	Jan. 12, 2018USD ($)$ / sharesshares	Jan. 12, 2018CAD ($)$ / sharesshares	Dec. 08, 2017USD ($)$ / sharesshares	Dec. 08, 2017CAD ($)$ / sharesshares	Oct. 07, 2016USD ($)shares	Aug. 31, 2018USD ($)$ / sharesshares	Aug. 31, 2018CAD ($)$ / sharesshares	May 25, 2018USD ($)$ / sharesshares	May 25, 2018CAD ($)$ / sharesshares	Feb. 28, 2018shares	Nov. 30, 2017USD ($)$ / sharesshares	Nov. 30, 2017CAD ($)$ / sharesshares	Apr. 30, 2017USD ($)$ / sharesshares	Apr. 30, 2017CAD ($)$ / sharesshares	Apr. 21, 2017USD ($)$ / sharesshares	Feb. 28, 2017USD ($)$ / sharesshares	Feb. 28, 2017CAD ($)$ / sharesshares	Jan. 20, 2017USD ($)$ / sharesshares	Jan. 20, 2017CAD ($)$ / sharesshares	Sep. 23, 2016USD ($)$ / sharesshares	Sep. 23, 2016CAD ($)$ / sharesshares	Aug. 31, 2018USD ($)$ / sharesshares	Aug. 31, 2017USD ($)$ / sharesshares	May 31, 2018shares
Units Issued During Period, Units	1,746,900	1,746,900		1,611,000	1,611,000	3,954,000	3,954,000		4,400,000	4,400,000	2,470,000	2,470,000		2,600,000	2,600,000	3,224,000	3,224,000		4,250,000	4,250,000	1,000,000	1,000,000	3,858,571	3,858,571
Units Issued During Period, Per Unit Amount | $ / shares		$ 0.06			$ 0.05		$ 0.05			$ 0.03		$ 0.06			$ 0.05		$ 0.09			$ 0.04		$ 0.04		$ 0.035
Units Issued During Period, Value	$ 81,987	$ 104,814		$ 64,371	$ 80,550	$ 154,397	$ 197,700		$ 101,111	$ 132,000	$ 114,822	$ 148,200		$ 101,198	$ 130,000	$ 214,933	$ 290,160		$ 125,926	$ 170,000	$ 29,630	$ 40,000	$ 100,037	$ 135,050
Class of Warrant or Right, Grants in Period, Contractual Term	24 months	24 months		24 months	24 months	24 months	24 months		36 months	36 months	24 months	24 months		24 months	24 months	24 months	24 months		24 months	24 months	24 months	24 months	24 months	24 months
Class of Warrant or Right, Grants in Period, Weighted Average Exercise Price | $ / shares	$ 0.075			$ 0.06		$ 0.06			$ 0.050		$ 0.075			$ 0.06		$ 0.12			$ 0.06		$ 0.06		$ 0.07		$ 0.06	$ 0.08
Payments of Stock Issuance Costs	$ 7,258	$ 9,281			$ 3,880	$ 9,938	$ 12,770		$ 9,192	$ 12,000	$ 4,488	$ 5,820					$ 20,736			$ 11,100		$ 800		$ 4,830	$ 3,103
Class of Warrant or Right, Grants in Period, Net of Forfeitures	144,690	144,690		77,600	77,600	230,400	230,400		400,000	400,000	70,000	70,000	1,000,000			230,400	230,400		227,500	227,500	20,000	20,000	138,000	138,000	17,704,590	13,948,471
Stock Issued During Period, Shares, New Issues								175,000	170,000	170,000
Stock Issued During Period, Value, New Issues | $								$ 7,000
Class of Warrant or Right, Exercises in Period			50,000													166,500	166,500	95,500							50,000	262,000
Proceeds from exercise of warrants | $			$ 3,500													$ 11,655		$ 5,685
Class of Warrant or Right, Exercises in Period, Exercise Price | $ / shares			$ 0.07													$ 0.07
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period	200,000	200,000				240,000	240,000																		(610,000)
Proceeds from Stock Options Exercised | $	$ 12,000					$ 12,000			$ 9,000																$ 33,000	$ 0
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | $ / shares	$ 0.06					$ 0.05																			$ 0.05
Common Stock, Shares, Issued									119,739,931	119,739,931															119,739,931	102,298,031	119,739,931
Common Stock, Shares, Outstanding									119,739,931	119,739,931															119,739,931	102,298,031
Equity Transaction 1 [Member]
Class of Warrant or Right, Exercises in Period, Exercise Price | $ / shares																		$ 0.05
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period									50,000	50,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | $ / shares									$ 0.06
Equity Transaction 2 [Member]
Class of Warrant or Right, Exercises in Period, Exercise Price | $ / shares																		$ 0.07
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period									120,000	120,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | $ / shares									$ 0.05

STOCK OPTIONS AND WARRANTS (Nar

STOCK OPTIONS AND WARRANTS (Narrative) (Details) - USD ($)	May 11, 2018	Feb. 02, 2018	Jan. 12, 2018	Dec. 08, 2017	May 02, 2017	Sep. 21, 2018	Aug. 31, 2018	May 25, 2018	May 22, 2018	Feb. 28, 2018	Nov. 30, 2017	Apr. 30, 2017	Apr. 21, 2017	Feb. 28, 2017	Jan. 31, 2017	Jan. 20, 2017	Sep. 23, 2016	Sep. 19, 2016	Aug. 31, 2018	Aug. 31, 2017	Aug. 31, 2016
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures	535,000				500,000				550,000		800,000				1,500,000	1,535,000		800,000	1,885,000	4,335,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price	$ 0.06				$ 0.10				$ 0.07		$ 0.05				$ 0.07	$ 0.07		$ 0.07	$ 0.06	$ 0.07
Stock based compensation										$ 29,168									$ 89,596	$ 227,428
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value							$ 0												$ 0
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period																				250,000
Class of Warrant or Right, Grants in Period, Net of Forfeitures	144,690		77,600	230,400			400,000	70,000		1,000,000		230,400		227,500		20,000	138,000		17,704,590	13,948,471
Class of Warrant or Right, Grants in Period, Exercise Price										$ 0.09
Share-based Goods and Nonemployee Services Transaction, Valuation Method, Expected Volatility Rate										182.00%
Share-based Goods and Nonemployee Services Transaction, Valuation Method, Risk Free Interest Rate										1.22%
Share-based Goods and Nonemployee Services Transaction, Valuation Method, Expected Term										6 months
Share-based Goods and Nonemployee Services Transaction, Valuation Method, Expected Dividend Rate										0.00%
Class of Warrant or Right, Exercises in Period		50,000										166,500	95,500						50,000	262,000
Proceeds from exercise of warrants		$ 3,500										$ 11,655	$ 5,685
Class of Warrant or Right, Exercises in Period, Exercise Price		$ 0.07										$ 0.07
Class of Warrant or Right, Expirations in Period																			16,107,340	3,906,800
Subsequent Event [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period																			250,000
Class of Warrant or Right, Grants in Period, Net of Forfeitures						202,500
Class of Warrant or Right, Expirations in Period																			3,946,571
Warrants attached to units [Member]
Class of Warrant or Right, Grants in Period, Net of Forfeitures																			16,781,900	12,332,571
Brokers warrants [Member]
Class of Warrant or Right, Grants in Period, Net of Forfeitures																			922,690	615,900
Share-based Goods and Nonemployee Services Transaction, Valuation Method, Expected Volatility Rate																			152.00%	168.00%
Share-based Goods and Nonemployee Services Transaction, Valuation Method, Risk Free Interest Rate																			2.10%	1.14%
Share-based Goods and Nonemployee Services Transaction, Valuation Method, Expected Term																			2 years 5 months 5 days	2 years
Share-based Goods and Nonemployee Services Transaction, Valuation Method, Expected Dividend Rate																			0.00%	0.00%
Warrants Issued During Period, Value																			$ 27,791	$ 33,213	$ 0
Equity Transaction 1 [Member]
Class of Warrant or Right, Exercises in Period, Exercise Price													$ 0.05
Equity Transaction 2 [Member]
Class of Warrant or Right, Exercises in Period, Exercise Price													$ 0.07

COMMITMENTS - OTHER (Narrative)

COMMITMENTS - OTHER (Narrative) (Details)	Aug. 31, 2018USD ($)
Consulting services	$ 3,500

INCOME TAXES (Narrative) (Detai

INCOME TAXES (Narrative) (Details) - USD ($)	1 Months Ended	12 Months Ended
	Jan. 31, 2017	Dec. 31, 2018	Aug. 30, 2018	Dec. 31, 2017	Aug. 30, 2017	Aug. 31, 2018
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate	34.00%	21.00%	25.30%	34.00%	34.00%
Net operating loss carry forwards						$ 12,963,000

SUBSEQUENT EVENTS (Narrative) (

SUBSEQUENT EVENTS (Narrative) (Details)	May 11, 2018USD ($)$ / sharesshares	May 11, 2018CAD ($)$ / sharesshares	Jan. 12, 2018USD ($)$ / sharesshares	Jan. 12, 2018CAD ($)$ / sharesshares	Dec. 08, 2017USD ($)$ / sharesshares	Dec. 08, 2017CAD ($)$ / sharesshares	Sep. 21, 2018USD ($)$ / sharesshares	Aug. 31, 2018USD ($)$ / sharesshares	Aug. 31, 2018CAD ($)$ / sharesshares	May 25, 2018USD ($)$ / sharesshares	May 25, 2018CAD ($)$ / sharesshares	Feb. 28, 2018shares	Nov. 30, 2017USD ($)$ / sharesshares	Nov. 30, 2017CAD ($)$ / sharesshares	Apr. 30, 2017USD ($)$ / sharesshares	Apr. 30, 2017CAD ($)$ / sharesshares	Feb. 28, 2017USD ($)$ / sharesshares	Feb. 28, 2017CAD ($)$ / sharesshares	Jan. 20, 2017USD ($)$ / sharesshares	Jan. 20, 2017CAD ($)$ / sharesshares	Sep. 23, 2016USD ($)$ / sharesshares	Sep. 23, 2016CAD ($)$ / sharesshares	Aug. 31, 2018USD ($)$ / sharesshares	Aug. 31, 2017$ / sharesshares
Units Issued During Period, Units | shares	1,746,900	1,746,900	1,611,000	1,611,000	3,954,000	3,954,000		4,400,000	4,400,000	2,470,000	2,470,000		2,600,000	2,600,000	3,224,000	3,224,000	4,250,000	4,250,000	1,000,000	1,000,000	3,858,571	3,858,571
Units Issued During Period, Per Unit Amount | $ / shares		$ 0.06		$ 0.05		$ 0.05			$ 0.03		$ 0.06			$ 0.05		$ 0.09		$ 0.04		$ 0.04		$ 0.035
Units Issued During Period, Value	$ 81,987	$ 104,814	$ 64,371	$ 80,550	$ 154,397	$ 197,700		$ 101,111	$ 132,000	$ 114,822	$ 148,200		$ 101,198	$ 130,000	$ 214,933	$ 290,160	$ 125,926	$ 170,000	$ 29,630	$ 40,000	$ 100,037	$ 135,050
Class of Warrant or Right, Grants in Period, Contractual Term	24 months	24 months	24 months	24 months	24 months	24 months		36 months	36 months	24 months	24 months		24 months	24 months	24 months	24 months	24 months	24 months	24 months	24 months	24 months	24 months
Class of Warrant or Right, Grants in Period, Weighted Average Exercise Price | $ / shares	$ 0.075		$ 0.06		$ 0.06			$ 0.050		$ 0.075			$ 0.06		$ 0.12		$ 0.06		$ 0.06		$ 0.07		$ 0.06	$ 0.08
Payments of Stock Issuance Costs	$ 7,258	$ 9,281		$ 3,880	$ 9,938	$ 12,770		$ 9,192	$ 12,000	$ 4,488	$ 5,820					$ 20,736		$ 11,100		$ 800		$ 4,830	$ 3,103
Class of Warrant or Right, Grants in Period, Net of Forfeitures | shares	144,690	144,690	77,600	77,600	230,400	230,400		400,000	400,000	70,000	70,000	1,000,000			230,400	230,400	227,500	227,500	20,000	20,000	138,000	138,000	17,704,590	13,948,471
Subsequent Event [Member]
Units Issued During Period, Units | shares							2,225,000
Units Issued During Period, Per Unit Amount | $ / shares							$ 0.03
Units Issued During Period, Value | $							$ 66,750
Class of Warrant or Right, Grants in Period, Contractual Term							36 months
Class of Warrant or Right, Grants in Period, Weighted Average Exercise Price | $ / shares							$ 0.05
Payments of Stock Issuance Costs | $							$ 6,075
Class of Warrant or Right, Grants in Period, Net of Forfeitures | shares							202,500

Schedule of Share-based Compens

Schedule of Share-based Compensation, Stock Options, Activity (Details) - $ / shares	May 11, 2018	Dec. 08, 2017	May 02, 2017	May 22, 2018	Nov. 30, 2017	Jan. 31, 2017	Jan. 20, 2017	Sep. 19, 2016	Aug. 31, 2018	Aug. 31, 2017
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number, Beginning of Period								3,210,000	7,295,000	3,210,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price, Beginning of Period								$ 0.07	$ 0.07	$ 0.07
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period										(250,000)
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price										$ 0.06
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures	535,000		500,000	550,000	800,000	1,500,000	1,535,000	800,000	1,885,000	4,335,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price	$ 0.06		$ 0.10	$ 0.07	$ 0.05	$ 0.07	$ 0.07	$ 0.07	$ 0.06	$ 0.07
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period	200,000	240,000							(610,000)
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price	$ 0.06	$ 0.05							$ 0.05
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number, End of Period									8,570,000	7,295,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price, End of Period									$ 0.07	$ 0.07

Schedule of Share-based Payment

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions (Details) - USD ($)	12 Months Ended
	Aug. 31, 2018	Aug. 31, 2017
Expected volatility	204.00%
Risk-free interest rate	1.93%
Expected life	5 years	5 years
Dividend yield	0.00%	0.00%
Estimated fair value per option	$ 0.05
Minimum [Member]
Expected volatility		182.00%
Risk-free interest rate		1.22%
Estimated fair value per option		$ 0.05
Maximum [Member]
Expected volatility		232.00%
Risk-free interest rate		1.95%
Estimated fair value per option		$ 0.09

Disclosure of Share-based Compe

Disclosure of Share-based Compensation Arrangements by Share-based Payment Award (Details) - $ / shares	12 Months Ended
	Aug. 31, 2018	Aug. 31, 2017	Aug. 31, 2016
Exercise prices	$ 0.07	$ 0.07	$ 0.07
Number of shares	8,570,000	7,295,000	3,210,000
Remaining contractual life	2 years 10 months 17 days	3 years 5 months 5 days
Option exercise price 1 [Member]
Exercise prices	$ 0.07	$ 0.10
Number of shares	550,000	500,000
Remaining contractual life	4 years 8 months 23 days	4 years 8 months 1 day
Option exercise price 2 [Member]
Exercise prices	$ 0.06	$ 0.07
Number of shares	535,000	1,500,000
Remaining contractual life	4 years 8 months 12 days	4 years 5 months 1 day
Option exercise price 3 [Member]
Exercise prices	$ 0.05	$ 0.07
Number of shares	800,000	1,535,000
Remaining contractual life	4 years 1 month 28 days	4 years 4 months 20 days
Option exercise price 4 [Member]
Exercise prices	$ 0.10	$ 0.07
Number of shares	500,000	800,000
Remaining contractual life	3 years 8 months 1 day	4 years 18 days
Option exercise price 5 [Member]
Exercise prices	$ 0.07	$ 0.05
Number of shares	1,500,000	1,460,000
Remaining contractual life	3 years 5 months 1 day	3 years 1 month 24 days
Option exercise price 6 [Member]
Exercise prices	$ 0.07	$ 0.10
Number of shares	1,535,000	1,000,000
Remaining contractual life	3 years 4 months 20 days	2 years 2 months 5 days
Option exercise price 7 [Member]
Exercise prices	$ 0.07	$ 0.06
Number of shares	800,000	500,000
Remaining contractual life	3 years 18 days	1 year 2 months 5 days
Option exercise price 8 [Member]
Exercise prices	$ 0.05
Number of shares	1,100,000
Remaining contractual life	2 years 1 month 24 days
Option exercise price 9 [Member]
Exercise prices	$ 0.10
Number of shares	1,000,000
Remaining contractual life	1 year 2 months 5 days
Option exercise price 10 [Member]
Exercise prices	$ 0.06
Number of shares	250,000
Remaining contractual life	2 months 5 days

Schedule of Stockholders' Equit

Schedule of Stockholders' Equity Note, Warrants or Rights, Activity (Details) - $ / shares	May 11, 2018	Feb. 02, 2018	Jan. 12, 2018	Dec. 08, 2017	Aug. 31, 2018	May 25, 2018	Feb. 28, 2018	Nov. 30, 2017	Apr. 30, 2017	Apr. 21, 2017	Feb. 28, 2017	Jan. 20, 2017	Sep. 23, 2016	Aug. 31, 2018	Aug. 31, 2017
Class of Warrant or Right, Outstanding, Beginning of Period													29,412,139	39,191,810	29,412,139
Class of Warrant or Right, Outstanding, Weighted Average Exercise Price, Beginning of Period													$ 0.09	$ 0.09	$ 0.09
Class of Warrant or Right, Expirations in Period														(16,107,340)	(3,906,800)
Class of Warrant or Right, Expirations in Period, Weighted Average Exercise Price														$ 0.12	$ 0.10
Class of Warrant or Right, Grants in Period, Net of Forfeitures	144,690		77,600	230,400	400,000	70,000	1,000,000		230,400		227,500	20,000	138,000	17,704,590	13,948,471
Class of Warrant or Right, Grants in Period, Weighted Average Exercise Price	$ 0.075		$ 0.06	$ 0.06	$ 0.050	$ 0.075		$ 0.06	$ 0.12		$ 0.06	$ 0.06	$ 0.07	$ 0.06	$ 0.08
Class of Warrant or Right, Exercises in Period		(50,000)							(166,500)	(95,500)				(50,000)	(262,000)
Class of Warrant or Right, Exercises in Period, Weighted Average Exercise Price														$ 0.07	$ 0.07
Class of Warrant or Right, Outstanding, End of Period					40,739,060									40,739,060	39,191,810
Class of Warrant or Right, Outstanding, Weighted Average Exercise Price, End of Period					$ 0.06									$ 0.06	$ 0.09

Schedule of Stockholders' Equ_2

Schedule of Stockholders' Equity Note, Warrants or Rights (Details) - $ / shares	Aug. 31, 2018	Aug. 31, 2017	Aug. 31, 2016
Number Outstanding	40,739,060	39,191,810	29,412,139
Warrant exercise price 1 [Member]
Number Outstanding	4,800,000
Exercise Price	$ 0.050
Warrant exercise price 2 [Member]
Number Outstanding	2,540,000
Exercise Price	$ 0.075
Warrant exercise price 3 [Member]
Number Outstanding	1,891,590
Exercise Price	$ 0.075
Warrant exercise price 4 [Member]
Number Outstanding	1,688,600
Exercise Price	$ 0.060
Warrant exercise price 5 [Member]
Number Outstanding	4,184,400
Exercise Price	$ 0.060
Warrant exercise price 6 [Member]
Number Outstanding	2,600,000
Exercise Price	$ 0.060
Warrant exercise price 7 [Member]
Number Outstanding	3,253,333
Exercise Price	$ 0.050
Warrant exercise price 7 [Member] | after 18 months [Member]
Exercise Price	$ 0.10
Warrant exercise price 8 [Member]
Number Outstanding	6,882,666
Exercise Price	$ 0.050
Warrant exercise price 8 [Member] | after 18 months [Member]
Exercise Price	$ 0.10
Warrant exercise price 9 [Member]
Number Outstanding	3,454,400
Exercise Price	$ 0.120
Warrant exercise price 10 [Member]
Number Outstanding	4,477,500
Exercise Price	$ 0.060
Warrant exercise price 11 [Member]
Number Outstanding	1,020,000
Exercise Price	$ 0.060
Warrant exercise price 12 [Member]
Number Outstanding	3,946,571
Exercise Price	$ 0.070

Schedule of Effective Income Ta

Schedule of Effective Income Tax Rate Reconciliation (Details) - USD ($)	1 Months Ended	12 Months Ended
	Jan. 31, 2017	Dec. 31, 2018	Aug. 30, 2018	Dec. 31, 2017	Aug. 30, 2017
Loss before taxes			$ (650,055)		$ (801,166)
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate	34.00%	21.00%	25.30%	34.00%	34.00%
Expected income tax recovery			$ (164,680)		$ (272,396)
Non-deductible items			22,698		77,326
Change in enacted rates and other			1,618,859		(40,132)
Adjustment to prior years provision versus statutory tax returns and expiry of non-capital losses			(65,410)		0
Share issuance costs			0		(17,769)
Change in valuation allowance			(1,411,467)		252,971
Income tax expense (recovery)			$ 0		$ 0

Schedule of Deferred Tax Assets

Schedule of Deferred Tax Assets and Liabilities (Details) - USD ($)	Aug. 30, 2018	Aug. 30, 2017
Net operating loss carry forwards	$ 2,722,136	$ 4,110,965
Capital loss carry forwards	4,526	7,328
Deferred tax assets, gross	2,764,446	4,175,912
Valuation allowance	2,764,446	4,175,912
Deferred tax assets (liabilities)	0	0
Marketable securities [Member]
Deferred tax assets, other	5,698	9,225
Financing costs [Member]
Deferred tax assets, other	7,253	15,839
Mineral property [Member]
Deferred tax assets, other	20,108	32,555
Intangible Assets [Member]
Deferred tax assets, other	$ 4,725	$ 0